参考资料:
[1] FDA warns of heart risks with Trump-promoted malaria drug
[2] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
[3] Chloroquine hype is derailing the search for coronavirus treatments
[4] The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
[5] Prescriptions Surged as Trump Praised Drugs in Coronavirus Fight
[6] Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems